Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Cash (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Change in Cash for 4 consecutive years, with $42.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Change in Cash fell 47.63% year-over-year to $42.0 million, compared with a TTM value of -$63.3 million through Dec 2023, down 166.27%, and an annual FY2024 reading of $81.5 million, up 228.75% over the prior year.
  • Change in Cash was $42.0 million for Q4 2023 at Terns Pharmaceuticals, up from -$43.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $80.3 million in Q4 2022 and bottomed at -$103.4 million in Q2 2023.
  • Average Change in Cash over 4 years is $4.2 million, with a median of -$1.7 million recorded in 2020.
  • Peak annual rise in Change in Cash hit 3899.52% in 2021, while the deepest fall reached 495.74% in 2021.
  • Year by year, Change in Cash stood at $61.0 million in 2020, then tumbled by 127.93% to -$17.1 million in 2021, then soared by 570.67% to $80.3 million in 2022, then plummeted by 47.63% to $42.0 million in 2023.
  • Business Quant data shows Change in Cash for TERN at $42.0 million in Q4 2023, -$43.0 million in Q3 2023, and -$103.4 million in Q2 2023.